TTN-AS1 and neoplasm: Additionally, TTN‐AS1 was also revealed to accelerate epithelial‐mesenchymal transition (EMT), tumor angiogenesis, and cell cycle progression by downregulating miR‐320a, thus promoting the migration and proliferation of cholangiocarcinoma.10